Lisofylline as a modifier of radiation therapy

Area of Science:

• Oncology
• Radiation Oncology
• Pharmacology

Background:

• Radiotherapy is a cornerstone of cancer treatment.
• Enhancing radiation efficacy, especially in hypoxic tumors, remains a critical challenge.
• Methylxanthines are being explored for their radiosensitizing properties.

Purpose of the Study:

• To evaluate the potential of lisofylline to enhance the response of EMT-6 murine mammary carcinoma to ionizing radiation.
• To compare the efficacy of lisofylline with pentoxifylline as a radiosensitizer.
• To investigate lisofylline's effects in both in vitro and in vivo models under varying radiation conditions.

Main Methods:

• In vitro assessment of lisofylline and pentoxifylline on EMT-6 cells exposed to gamma-radiation at different dose rates (0.76 Gy/min and 12.3 Gy/min).
• In vivo evaluation using tumor cell survival assays and tumor growth delay assays in a murine model.
• Determination of dose modifying factors (DMF) for both agents under hypoxic and normally oxygenated conditions.

Main Results:

• Lisofylline and pentoxifylline did not alter the response of normally oxygenated EMT-6 cells to gamma-radiation.
• Both agents demonstrated a dose modifying factor of 2.3 for hypoxic EMT-6 cells at a radiation dose rate of 0.76 Gy/min.
• Lisofylline showed a DMF of 1.2 in the high dose rate radiation setting for hypoxic cells.
• In vivo, lisofylline reduced the shoulder of the radiation survival curve by a factor of 1.7 +/- 0.2, an effect not observed with pentoxifylline.
• Lisofylline demonstrated greater efficacy in modifying gamma-radiation therapy compared to pentoxifylline.

Conclusions:

• Lisofylline is a more effective radiosensitizer than pentoxifylline for EMT-6 murine mammary carcinoma, particularly under hypoxic conditions.
• Lisofylline's ability to modify the radiation survival curve in vivo warrants further investigation for its clinical application in radiation therapy.
• Further research into lisofylline's mechanism of action and therapeutic potential in combination with radiation is recommended.